These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2197335)

  • 1. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children.
    Steinhoff MC; Halsey NA; Wilson MH; Burns BA; Samorodin RK; Fries LF; Murphy BR; Clements ML
    J Infect Dis; 1990 Aug; 162(2):394-401. PubMed ID: 2197335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.
    Sears SD; Clements ML; Betts RF; Maassab HF; Murphy BR; Snyder MH
    J Infect Dis; 1988 Dec; 158(6):1209-19. PubMed ID: 3198936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the virologic and immunologic responses of volunteers to live avian-human influenza A H3N2 reassortant virus vaccines derived from two different avian influenza virus donors.
    Clements ML; Sears SD; Christina K; Murphy BR; Snyder MH
    J Clin Microbiol; 1989 Jan; 27(1):219-22. PubMed ID: 2913033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.
    Steinhoff MC; Halsey NA; Fries LF; Wilson MH; King J; Burns BA; Samorodin RK; Perkis V; Murphy BR; Clements ML
    J Infect Dis; 1991 May; 163(5):1023-8. PubMed ID: 2019751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers.
    Clements ML; Snyder MH; Sears SD; Maassab HF; Murphy BR
    J Infect Dis; 1990 May; 161(5):869-77. PubMed ID: 2324538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children.
    Edwards KM; King JC; Steinhoff MC; Thompson J; Clements ML; Wright PF; Murphy BR
    J Infect Dis; 1991 Apr; 163(4):740-5. PubMed ID: 2010627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
    Treanor JJ; Roth FK; Betts RF
    J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.
    Snyder MH; Clements ML; Betts RF; Dolin R; Buckler-White AJ; Tierney EL; Murphy BR
    J Clin Microbiol; 1986 May; 23(5):852-7. PubMed ID: 3711273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
    Clements ML; O'Donnell S; Levine MM; Chanock RM; Murphy BR
    Infect Immun; 1983 Jun; 40(3):1044-51. PubMed ID: 6852910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children.
    Edwards KM; Snyder P; Thompson JM; Johnson PR; Wright PF
    Vaccine; 1986 Mar; 4(1):50-4. PubMed ID: 3962451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.
    Gruber WC; Darden PM; Still JG; Lohr J; Reed G; Wright PF
    Vaccine; 1997; 15(12-13):1379-84. PubMed ID: 9302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group.
    Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F
    J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML; Betts RF; Murphy BR
    Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.
    Clements ML; Makhene MK; Karron RA; Murphy BR; Steinhoff MC; Subbarao K; Wilson MH; Wright PF
    J Infect Dis; 1996 Jan; 173(1):44-51. PubMed ID: 8537681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine.
    Johnson PR; Feldman S; Thompson JM; Mahoney JD; Wright PF
    J Infect Dis; 1986 Jul; 154(1):121-7. PubMed ID: 3711685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.
    Anderson EL; Newman FK; Maassab HF; Belshe RB
    J Clin Microbiol; 1992 Sep; 30(9):2230-4. PubMed ID: 1400985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers.
    Clements ML; Betts RF; Maassab HF; Murphy BR
    J Infect Dis; 1984 May; 149(5):814-5. PubMed ID: 6726006
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus.
    Feldman S; Wright PF; Webster RG; Roberson PK; Mahoney J; Thompson J; Doolittle M; Lott L; Johnson P; Christoph RC
    J Infect Dis; 1985 Dec; 152(6):1212-8. PubMed ID: 3905983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
    Piedra PA; Glezen WP; Mbawuike I; Gruber WC; Baxter BD; Boland FJ; Byrd RW; Fan LL; Lewis JK; Rhodes LJ
    Vaccine; 1993; 11(7):718-24. PubMed ID: 8342319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.